Minimizing the environmental impact of our operations is essential to promoting healthy communities that thrive on a clean and sustainable planet.
We focus our environmental sustainability efforts on mitigating the impacts of our operations on climate, water, and waste; and complying with environmental regulations. We know that key stakeholders, including employees, customers and investors, share our values of operational excellence and environmental responsibility, and we work with them to make progress against our goals.
We achieved our initial goal of reducing our site-based carbon emissions by 15% by fiscal 2023[a] [b], which we set in fiscal 2019. As of July 1, 2021, that initial goal was met and surpassed, driven by an accelerated renewable energy contract strategy.
We recently signed a letter of commitment with the Science Based Target initiative (SBTi), joining a growing list of companies setting actionable, science-based, greenhouse gas emission reduction targets to limit global warming. This commitment will include calculating and reducing direct and indirect emissions as our company continues to evolve and grow. Catalent will establish and announce its Science Based Targets by fiscal 2024, following the SBTi process.
We are currently on track to achieve our other environmental performance goals including:
- Water intensity reduction to 500 m3 / M$ revenue by fiscal 2024
- No residual active pharmaceutical ingredients (API) above predicted no effect concentration level[c] (PNEC) in wastewater by fiscal 2024
- Zero waste sent to landfill by fiscal 2024
1 Environmental Performance Goals are for 34 Catalent manufacturing sites.
a From fiscal 2018 baseline
b Carbon emissions target includes Scope 1 and Scope 2 emissions.
c Defined by the European Chemicals Agency REACH Regulation as the concentration of a substance below which adverse effects in the environmental sphere of concern are not expected to occur.
Our approach to environmental management
Our Standards of Business Conduct commit Catalent to minimize our impact on the environment, complying with relevant laws, operating with the required environmental permits and controls, and promoting a culture of sustainability in our operations.
Our Environmental Health and Safety (EHS) culture helps to integrate environmental responsibility and sustainability into our decisions and operations. The EHS Policy signed by our President and COO, outlines our company-wide environmental stewardship objectives and commitments, and our expectations for employees to comply.
Across the global network, we streamline operating standards, procedures, and training through an ISO14001-accredited environmental management system. In fiscal 2020, we increased the scope of our accreditation to 33 sites, up from 24 in fiscal 2019.
Our sites report environmental data through a central platform and our sustainability progress is tracked with an internal sustainability scorecard. The data guides our environmental strategy and helps our sites improve operational best practices and minimize our footprint.
Reducing our carbon footprint
As a science-based company, we are concerned about climate change and its potential impact on human health and the environment. We are committed to operating responsibly and to continuously minimizing our carbon footprint.
Since fiscal 2019, we completed more than 60 site-based energy efficiency projects, ranging from replacing major equipment to installing more efficient LED lighting. As a result, we avoided 9,500 MT of carbon dioxide equivalent. You can learn more and access our energy and emissions data in our latest Corporate Responsibility report.
Since the start of fiscal 2022, 97% of our electricity usage across our global network is being procured from renewable energy sources such as wind, solar, hydroelectric, and biomass. Catalent will purchase renewable energy certificates for all its sites operating in North America, South America and Europe, as well as the majority of its Asia-based facilities.
We aim to minimize our water usage and to meet or exceed regulatory requirements for wastewater discharge. Our goal is to reduce our water intensity to 500 cubic meters (m3) per million US dollars of revenue by fiscal 2024. We plan to achieve this by investing in water reduction, recycling, and reuse initiatives at our most water-intensive facilities. These projects will build on existing water conservation programs at our sites.
Responsibly disposing of residual API in wastewater is a critical issue for the biopharma sector. We take a risk-based approach to minimizing API in wastewater. Our goal is that by fiscal 2024, all sites will discharge wastewater with API concentrations below PNEC levels.
Check out our latest Corporate Responsibility report for more information and data on our water efficiency and responsible management efforts.
Improving waste management
A key way to reduce our waste impact is to eliminate the need to send non-hazardous waste to landfill and by managing hazardous waste responsibly. Our approach, aligned with regulatory requirements and ISO14001, requires sites to monitor waste and to implement an elimination or minimization plan. Our approach to waste reduction includes limiting the volume of nonessential material brought onto our sites, segregating waste streams, and diverting waste from landfill.
Seventeen sites in our network, representing 50% of our manufacturing sites, no longer send waste to landfills. To reach our fiscal 2024 goal, we are finalizing plans at our remaining sites to divert landfill material to recycling, reuse, or incineration.
Some of our most recent waste diversion initiatives included:
- Expanding programs to divert discarded personal protective equipment from landfill, including nitrile gloves
- Increasing the amount of excess gelatin that we recycle or reuse
You can review our waste management data and details on the programs in our latest Corporate Responsibility report
ENVIRONMENTAL IMPACT OF OUR SUPPLY CHAIN
As a member of the Pharmaceutical Supply Chain Initiative (PSCI), a group of companies from the healthcare and pharmaceutical sector dedicated to improving the industry’s social and environmental impacts, we engage with industry peers on social and environmental best practices. Click here to learn about the guiding principles of PSCI.
In fiscal 2021, our internal Procurement team will distribute social and environmental assessments to select suppliers. The results of this pilot will guide our approach to scaling our responsible supplier audit program in the future.
CATALENT GREEN TEAMS
Employees are a key driver of our corporate responsibility & sustainability culture and strategy. Greens teams, local groups of employees that organize environmental actions, share best practices and raise sustainability awareness at our sites and in our communities, are expanding across the network. Examples of our cross-network technical green teams include the green labs practice team, the carbon and energy reduction tools team, and the waste & water special interest group.
Catalent San Diego Green Team organized a park clean-up to recognize Earth Month.
For more information on Corporate Responsibility & Sustainability at Catalent, email us or follow #catalentcares on social media.